Oral g-C3N4-based nanosheets as a universal metal antagonist inhibit cuproptosis pathway for reversing inflammation and injury of Wilson's disease

Xiaoying Xu(Macau University of Science and Technology), Leung Chan(First Affiliated Hospital of Jinan University), Yongjun Peng(Zhuhai People's Hospital), Weiguo Xu(Chinese Academy of Sciences), Fei Liu(Anhui Agricultural University), Wei Zhao(Zhuhai People's Hospital), Yanhong Su(Karolinska Institutet), Ke He(Second Affiliated Hospital of Guangzhou Medical University), Meixiao Zhan(Zhuhai People's Hospital), Qiu Li(Macau University of Science and Technology), Ligong Lu(Tongji University)
Chemical Engineering Journal
June 13, 2025
10.1016/j.cej.2025.164864
Cited by 0

Related Papers

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
|JAMA|2020|229
Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer
|Nature Communications|2018|209
Psoriasis and cardiovascular disease risk in European and East Asian populations: evidence from meta-analysis and Mendelian randomization analysis
|BMC Medicine|2022|74
Anti‐Inflammatory Nanotherapeutics by Targeting Matrix Metalloproteinases for Immunotherapy of Spinal Cord Injury
|Small|2021|70